In this report, 30 tetracycline-resistant clinical isolates of group B Streptococcus were examined to assess the extent to which tetracycline resistance is plasmid mediated. Of these, 27 showed no physical or genetic evidence of plasmidmediated resistance; however, one conjugative and two small (3.5 x 106-dalton) multicopy non-self-transmissible tetracycline resistance plasmids were identified.
Since 1957, there has been a significant increase in the incidence of tetracycline resistance among clinical isolates of species of Streptococcus (1, 2, 9, 15, 22, 28), and tetracycline (Tc) resistance is now commonly encountered. Surveys of Streptococcus pyogenes since 1974 (22) and Streptococcus agalactiae (group B) in 1976 (1, 9) found that 80% and 87.6% of the isolates, respectively, were resistant to high levels of tetracycline. However, only in a few cases has tetracycline resistance in Streptococcus been shown to be mediated by plasmids (4, 5, 8, 14, 29) . These reports have all been confined to Streptococcus faecalis (group D) , and no systematic analysis of the genetic basis of tetracycline resistance has been carried out.
In this report I extend my previous observations (11) on a plasmid transfer system to assess the extent to which tetracycline resistance determinants in group B Streptococcus are plasmid mediated. In the course of this work, 92.4% of 433 clinical isolates tested were resistant to tetracycline, and in the majority of cases we were unable to identify tetracycline resistance plasmids. Of 30 strains examined in detail, only 3 were found to contain tetracycline resistance plasmids. This is in contrast to the findings with gram-negative bacteria, whose tetracycline resistance is almost always plasmid associated. Of particular significance, two of the plasmids were small multicopy plasmids which readily transformed Streptococcus sanguis Challis. These properties render them attractive as vehicles for cloning in this system. MATERIALS AND METHODS Bacterial strains. S. agalactiae (group B) strains (Table 1) were identified from clinical samples by being weakly beta-hemolytic on sheep blood agar, positive in the CAMP (3) test, hippurate positive, and bile esculin negative, and were confirmed serologically by the method of Rantz and Randall (23) .
Twenty-four strains were selected at random from among 433 independent clinical isolates collected over a 2-year period at the Duke University Medical Center. Six strains from Torrance, Calif. (1) (MV158, MV159, MV160, MV161, MV162, MV163), also represent independent isolates and are of several different serotypes. Other strains used are listed in Table 2 . For clarity, subscripts following the strain designation will be used to differentiate the serotypes, e.g., JH2-2D is a group D Streptococcus, and MV158B is a group B isolate.
Spontaneous mutants to rifampin resistance (rif) and streptomycin resistance (str) were obtained by plating broth cultures on solid media containing 100 yg and 1,000 jig of the antibiotic, respectively, per ml.
Minimum inhibitory concentrations were determined on brain heart infusion agar (BHIA) plates containing doubling concentrations of antibiotic, by using a Steers multiple inoculator (27 (17) . Cells were grown to competence in BHIB with 10% heat-inactivated out further enrichment. Dye-buoyant density gradient centrifugation was carried out on plasmid-enriched fractions prepared as described above from 300 ml of culture. Fractions containing supercoiled plasmid DNA were pooled, the dye was extracted with nbutanol, and the samples were dialyzed against buffer (10 mM Tris-hydrochloride [pH 7.5]-50 mM NaCl-0.1 mM EDTA). Restriction endonuclease analysis. Restriction enzymes HpaI, BglII, and HindIII were purchased from Bethesda Research Laboratories and used according to recommended reaction conditions. EcoRI was a gift from P. Modrich.
Agarose gel electrophoresis. Plasmid DNAs were analyzed by electrophoresis on 0.7 or 1% agarose gels in Tris-borate buffer (10) at 8 V/cm for 3 h. Gels were stained in 0.5,ug of ethidium bromide per ml and photographed with a Polaroid MP-4 camera using type 665 film through Wrattan no. 23 plus ultraviolet filters.
RESULTS
The scheme used to screen the clinical isolates for potential tetracycline resistance plasmids is shown in Fig. 1 . Two different recipient strains were used in every mating experiment. JH2-2D is a widely used S. faecalis strain resistant to rifampin and fusidic acid. The other recipient was MV762B, a plasmid-free pigmented group B strain made resistant to streptomycin (2,500 ,ug/ ml) and rifampin (1,000 ,ug/ml). Rifampin was used as the marker selective for the recipient because the frequency of mutation to high-level resistance among most donor strains is low. Spontaneous mutation to tetracycline resistance among these recipient strains was not encountered.
The first step was to use tetracycline-resistant Presumptive transconjugants obtained from each positive mating were analyzed for unselected chromosomal markers, including streptomycin resistance and pigmentation for MV762B and positive bile-esculin reaction and lack of hemolysis on sheep blood agar for JH2-2D. This was important since the colonies sometimes observed on plates selective for transconjugants (tetracycline, 2 ,ug/ml; rifampin, 50 ,tg/ml) were Rifr mutants of the donor strain being tested. If transfer or mobilization occurred, the parent strains as well as two transconjugants were tested for the presence of plasmid DNA.
Conjugative and nonconjugative tetracycline-resistant strains. By using the procedure outlined above, one conjugative (pMV120) and two nonconjugative (pMV158 and pMV163) plasmids were tentatively identified. Table 3 shows representative data for these strains as well as data representative of strains from which no transfer could be demonstrated. Twenty-four additional strains fell into the latter category (data not included). In every case, the sex factor pAM,Bl transferred at -4.2 x 10-2 per donor colony-forming unit, and in two strains the presence of the sex factor was necessary for transfer of the two mobilizable plasmids.
Since a number of conjugative plasmids have been described in S. faecalis (6, 8, 14, 29) , S. agalactiae (11, 12) , and S. pyogenes (21) , the question was posed whether sex factors other than pAM,Bl could mobilize these non-self-transmissible plasmids (NTPs). JH2-2D(pAMal) was included in the study at this point as a known NTP from S. faecalis. MV158B, MV163B, and JH2-2D(pAMal) derivatives were constructed containing the following sex factors: pAMf8l, pMV103, pIP501, pJH4, and ERL1. These conjugative plasmids (Table 2 ) all mediate erythromycin (macrolide)-lincosamide-streptogramin B (MLS) resistance with and without additional markers. In this way, sex factor transfer could be monitored independent of the NTP. The recipient was JH2-2D [except that JH203D was used when the donor was a JH2-2D(pAMal) derivative]. These data are presented in Table  4 . The significant results of this series of experiments were: (i) ERLi, originally described in S.
pyogenes 13234, was demonstrated to be a sex factor and was able to mobilize the tetracycline resistance plasmids studied; (ii) all the sex factors were able to mobilize all the NTPs to JH2-2D or JH203D; (iii) pMV158 was mobilized best VOL. 18, 1980 a Strains containing tetracycline-resistant NTPs and one of several MLS-resistant sex factors were used as donors in 6-h filter matings with JH2-2D in a donor-to-recipient ratio of 1:10. Transfer frequencies of both the sex factor (plates supplemented with erythromycin, 10 yg/ml, and rifampin, 50 jig/ml, or with erythromycin, 10 uig/ml, and streptomycin, 1,000 ug/ml) and NTP (plates supplemented with tetracycline, 2 iLg/ml, and rifampin, 50 ,ug/ml, or with tetracycline, 2 jg/ml, and streptomycin, 1,000 ug/ml) were determined independently. From each set of selection conditions, 50 or 100 colonies were picked to confirm the recipient phenotype and test cotransfer of the other plasmid. Em Tc; Tc and Em Tc; Em are the number resistant to both erythromycin and tetracycline when initial selection was made on tetracycline or on erythromycin, respectively. Resistance characteristics. Stable strains containing Tcr plasmids of low (pMV120, pIP614, pJHl) and high (pMV158, pMV163, pAMal) copy number (see following section) exhibited levels of resistance 10 to 30 times greater than the host background. The degree of enhanced resistance does not correlate with the copy number, suggesting that a single copy of the gene is sufficient to saturate all sites in the cell, assuming that there is a single type of tetracycline resistance. We also asked whether plasmid-mediated tetracycline resistance and chromosomal resistances could be distinguished on the basis of their pattern of expression. Single and multicopy streptococcal plasmids were tested in the original host as well as JH2-2D and MV762B host backgrounds. In all cases, tetracycline resistance was shown to be constitutively expressed. As a control for inducible expression of tetracycline resistance, Escherichia coli containing pSC101 was tested and showed growth typical of an inducible resistance under the same set of conditions used to test the streptococcal strains.
Attempts to cure plasmid-containing strains of tetracycline resistance by growth at 42°C or growth in the presence of acridine orange (0.5 to 10 ug/ml) were negative. Tests on over 1,000 colonies of each strain were carried out using parental strains. Failure to cure is not uncommon in the case of some multicopy plasmids.
Plasmids. Lysates of parental strains and transconjugants from a number of matings were enriched for plasmid DNA and analyzed by agarose gel electrophoresis. Two forms of pMV158 and pMV163 were present, corresponding to co- valently closed circular and open circular molecules. In all cases, the plasmids that were recovered corresponded to the resistance phenotype of the strain. Plasmids from transconjugants from different rounds of transfer appeared identical in mobility to plasmid DNA isolated from the parental strains. Figure 2 shows examples of plasmids recovered from parental strains and transconjugants of different phenotypes.
Accurate measure of molecular weights can be obtained from linearized DNA or the sum of the size of fragments generated by site-specific endonucleases. Such digests are shown in Fig. 3 . The sizes of the plasmids are 45,000 base pairs for pMV120, 5,200 base pairs for pMV158, and 5,400 base pairs for pMV163, calculated from this and other gels. Based on recovery of satellite DNA from cesium chloride-ethidium bromide gradients, pMV120 exists in three to five copies, whereas pMV158 and pMV153 have greater than 50 copies per chromosome.
The strains that showed no genetic evidence for the presence of plasmids were also examined for the presence of plasmid DNA. Several lysis procedures (11, 20) which routinely yielded plasmid from known strains were consistently negative even when cells were labeled with [3H] thymidine and DNA was centrifuged in cesium chloride-ethidium bromide gradients.
Transformation. We sought to use transformation as further confirmation that the tetracycline resistance phenotype is plasmid associated. S. sanguis (V288H) was used as the recipient in attempts to transform plasmid DNA from MV158B, MV163B, and JH2-2D(pAMal). Plasmid DNA was mixed with competent cells at 370C, and transformation was allowed to proceed for 3 h. No tetracycline-resistant colonies were observed in control cultures or when pAMal plasmid DNA was used. Plasmids pMV158 and pMV163 were able to effect transformation of V288H at frequencies of about 4 x 10-5 transformants per recipient per Ag. The V288H host strain is completely inhibited by 0.1 ,ug of tetracycline per ml. However, pMV158 and pMV163 transformants required minimum inhibitory concentrations of 2.5 jig/ml. The presence of these plasmids had no effect on colony morphology or sugar fermentation pattern of V288H.
DNA from V288H and V288H transformants was extracted and analyzed by electrophoresis on 0.7% agarose gels. V288H gave only a band of chromosomal DNA,whereas transformants contained a plasmid which comigrated with purified plasmid DNA isolated from the parent strain (Fig. 4) . 
